Bioavailability and platelet aggregation inhibitory activity of solufenum. A comparison with ibuprofen.
Bioavailability and platelet aggregation inhibitory activity of the lysine salt of ibuprofen (solufenum) were compared with those of the parent molecule in 5 healthy male volunteers. The study had a randomized, cross-over design. The average peak plasma level and the area under the curve were higher when solufenum was administered orally as compared to the same preparation given i.m. or as compared to oral ibuprofen. However, the bioavailability of the 3 preparations studied was not significantly different. In contrast, the inhibitory effect on adrenaline-induced platelet aggregation appeared significantly different. In contrast, the inhibitory effect on adrenaline-induced platelet aggregation appeared significantly earlier after the administration of both solufenum than after ibuprofen. The clinical relevance of these findings is discussed.
D000328:Adult; D001682:Biological Availability; D004837:Epinephrine / Q000494:pharmacology; D006801:Humans; D007052:Ibuprofen / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology*; D007408:Intestinal Absorption; D008297:Male; D010974:Platelet Aggregation / Q000187:drug effects*; D013997:Time Factors
D007052:Ibuprofen; D004837:Epinephrine